You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for United States v. BYERLY (D.D.C. 2021)

✉ Email this page to a colleague

« Back to Dashboard

United States v. BYERLY (D.D.C. 2021)

Docket	⤷ Sign Up	Date Filed	2021-08-20
Court	District Court, District of Columbia	Date Terminated
Cause		Assigned To	Randolph Daniel Moss
Jury Demand		Referred To
Patents	8,123,716
Link to Docket	External link to docket

Biologic Drugs cited in United States v. BYERLY

The biologic drugs covered by the patent cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for United States v. BYERLY (D.D.C. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-10-14	50	Attachment 2	coating and method 8,123,716 Pericardial delivery of treatment…U. S. patents and numerous pending and international patents, I currently hold the most patents on electrical…million people have had devices with some of these patented features in their chest, monitoring every heartbeat… Boston Scientific re US #6895280, Wash. DC. US Patent Appeals Board. (Apr 2018) P 2. Nevro v Boston…Boston Scientific re US #7587241, Wash. DC. US Patent Appeals Board. (Apr 2018) P 3. Aguilar v Los Angeles	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.